Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2024 Earnings Call Transcript February 11, 2025
Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.56 EPS, expectations were $-1.54.
Operator: Good afternoon. Welcome to Sage Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Sage’s website at sagerx.com. This call is the...
